INTELLIPHARMACEUTICS INTERNATIONAL INC.: 20-F/A filed 2013-02-01

Name: INTELLIPHARMACEUTICS INTERNATIONAL INC.: 20-F/A filed 2013-02-01
Creator: INTELLIPHARMACEUTICS INTERNATIONAL INC.
License: https://creativecommons.org/licenses/by/4.0/

What INTELLIPHARMACEUTICS INTERNATIONAL INC. reported in its annual report amendment (foreign private issuer) filed 2013-02-01 (fiscal FY 2012): 32 published measures, 86 facts as tagged in accession 0001171843-13-000369.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 20-F/A (annual report amendment (foreign private issuer))
Filed: 2013-02-01
Fiscal period: fiscal FY 2012
Accession: 0001171843-13-000369 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All INTELLIPHARMACEUTICS INTERNATIONAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2012-11-30	2,474,878	USD
At 2011-11-30	6,247,228	USD
At 2010-11-30	3,267,706	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-11-30	4,242,755	USD
At 2011-11-30	9,340,258	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2012-11-30	-1,767,877	USD
At 2011-11-30	-3,093,030	USD
At 2010-11-30	92,956	USD
At 2009-11-30	4,632,014	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-11-30	497,016	USD
At 2011-11-30	4,817,088	USD
At 2010-11-30	789,136	USD
At 2009-11-30	8,014,492	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	-6,136,865	USD	366
2010-12-01 to 2011-11-30	-4,880,277	USD	365
2009-12-01 to 2010-11-30	-5,761,091	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	-7,654,361	USD	366
2010-12-01 to 2011-11-30	-6,981,448	USD	365
2009-12-01 to 2010-11-30	-6,194,195	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	1,036,092	USD	366
2010-12-01 to 2011-11-30	262,142	USD	365
2009-12-01 to 2010-11-30	133,878	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	107,091	USD	366
2010-12-01 to 2011-11-30	501,814	USD	365
2009-12-01 to 2010-11-30	1,459,385	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	4,363,865	USD	366
2010-12-01 to 2011-11-30	11,269,162	USD	365
2009-12-01 to 2010-11-30	-907,001	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	-1,036,092	USD	366
2010-12-01 to 2011-11-30	-262,142	USD	365
2009-12-01 to 2010-11-30	-133,878	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit
At 2012-11-30	-30,084,684	USD
At 2011-11-30	-23,947,819	USD
At 2010-11-30	-19,067,542	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2011-12-01 to 2012-11-30	USD	366
2010-12-01 to 2011-11-30	USD	365
2009-12-01 to 2010-11-30	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit
At 2012-11-30	1,535,703	USD
At 2011-11-30	951,914	USD
At 2010-11-30	925,554	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	2,323,845	USD	366
2010-12-01 to 2011-11-30	702,460	USD	365
2009-12-01 to 2010-11-30	1,023,626	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-11-30	939,175	USD
At 2011-11-30	5,295,314	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	63,406	USD	366
2010-12-01 to 2011-11-30	83,473	USD	365
2009-12-01 to 2010-11-30	98,435	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-11-30	2,235,620	USD
At 2011-11-30	2,526,946	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-11-30	512,360	USD
At 2011-11-30	554,210	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-11-30	2,778	USD
At 2011-11-30	3,383	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	3,672,313	USD	366
2010-12-01 to 2011-11-30	2,925,454	USD	365
2009-12-01 to 2010-11-30	2,699,204	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	5,992,417	USD	366
2010-12-01 to 2011-11-30	5,125,608	USD	365
2009-12-01 to 2010-11-30	4,533,310	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-11-30	17,906,937	shares
At 2011-11-30	15,908,444	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-11-30	28,409,665	USD
At 2011-11-30	20,822,672	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-11-30	-240,010	USD
At 2011-11-30	-115,035	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-11-30	4,532,101	USD
At 2011-11-30	3,496,008	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-11-30	2,996,398	USD
At 2011-11-30	2,544,094	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-11-30	224,797	USD
At 2011-11-30	436,154	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-11-30	137,449	USD
At 2011-11-30	124,982	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2012-11-30	0	USD
At 2011-11-30	0	USD
At 2010-11-30	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	-6,261,840	USD	366
2010-12-01 to 2011-11-30	-4,769,836	USD	365
2009-12-01 to 2010-11-30	-5,644,723	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	452,303	USD	366
2010-12-01 to 2011-11-30	227,456	USD	365
2009-12-01 to 2010-11-30	242,778	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-12-01 to 2012-11-30	-605	USD	366
2010-12-01 to 2011-11-30	1,764	USD	365
2009-12-01 to 2010-11-30	-3,808	USD	365

Inspect the source

Entity: INTELLIPHARMACEUTICS INTERNATIONAL INC. / CIK 0001474835
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: b43bbafa3486320e53e47da45874c043f53139ec0b74aaba3fa200c8a1927667

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001474835.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))